Abstract:Abstract Background Long non-coding RNAs (lncRNAs) play a vital role in the genesis and development of human cancer. LncRNA MIR99AHG has been reported to be upregulated in acute myeloid leukemia (AML); however, its function in gastric cancer (GC) is still not clear. Here we were aiming to screen the prognostic lncRNA candidates and to explore the function of MIR99AHG in GC. Methods We have preliminarily screened some candidate lncRNA biomarkers in GC tissues through analyzing microarray datasets. The expression level of MIR99AHG in GC cell lines and tissues was monitored via qPCR. Survival analysis was performed with the patients of our hospital and TCGA database cases. CCK-8 assay, trans-well assay and flow cytometry were performed to determine cell proliferation, invasion, migration and apoptosis. Meanwhile, a target of MIR99AHG was predicted and identified by luciferase reporter gene detection experiments. Results MIR99AHG was strongly up-regulated in human GC and contributed to cancer progression. Kaplan–Meier analysis revealed that up-regulating MIR99AHG expression was positively correlated with unfavorable overall survival (P < 0.01) of patients from our hospital and TCGA database. Knockdown of MIR99AHG expression inhibited cell proliferation, invasion, migration and promoted cell apoptosis. Moreover, MIR99AHG worked as an oncogenic gene though competing for endogenous RNA (ceRNA) of miR-577. Conclusions Our findings suggested that MIR99AHG contributes to malignant phenotypes of GC and may become a promising therapeutic target.

The Role Of Mirna And Lncrna In Gastric Cancer

Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer

Non-coding RNAs and gastric cancer

The functional sites of miRNAs and lncRNAs in gastric carcinogenesis

Roles of Long Non-Coding RNAs in Gastric Cancer Metastasis

Roles of long noncoding RNAs in gastric cancer and their clinical applications

Mirna: the Nemesis of Gastric Cancer (Review)

LncRNAs: emerging biomarkers in gastric cancer

[Review on the Research Progress of the Role of Mirnas in Gastric Cancer].

Roles of Competing Endogenous RNAs in Gastric Cancer.

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells

Regulatory function of DNA methylation mediated lncRNAs in gastric cancer

The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer

Noncoding RNAs in gastric cancer: implications for drug resistance

Transcriptome analysis of miRNA–lncRNA–mRNA interactions in the malignant transformation process of gastric cancer initiation

Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

LncRNA Expression Profile Reveals the Potential Role of Lncrnas in Gastric Carcinogenesis.

Recent Advances of Mirnas in the Development and Clinical Application of Gastric Cancer

Long Non-Coding RNAs in Gastric Cancer: New Emerging Biological Functions and Therapeutic Implications

Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis